3 Cancer Treatment Stocks to Buy Right Now
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.
Iovance Biotherapeutics, Inc.
IOVA
IOVA
$24.71
$0.21
0.9%
BATS BZX Real Time Price as of December 4, 2019, 4:00 p.m. EST
View Interactive IOVA Charts
Iovance Biotherapeutics, Inc.
News & Analysis: Iovance Biotherapeutics, Inc.
Why Iovance Biotherapeutics Shares Are Soaring Today
Good news from the biotech's mid-stage clinical study is exciting investors.
Iovance Biotherapeutics, Inc. (IOVA) Q3 2019 Earnings Call Transcript
IOVA earnings call for the period ending September 30, 2019.
Iovance Biotherapeutics: Buy the Dip?
The company is flush with cash and wields a promising therapeutic pipeline. Is its recent tumble a buying opportunity?
Iovance Biotherapeutics, Inc. (IOVA) Q2 2019 Earnings Call Transcript
IOVA earnings call for the period ending June 30, 2019.
3 Top Biotech Stocks to Buy Right Now
These three biotech stocks might be outstanding buys right now.
Why Iovance Biotherapeutics Stock Soared 50% in June
The clinical-stage biopharma announced promising data at a major conference.
3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks could be outstanding additions to your portfolio.
Why Iovance Biotherapeutics Stock Jumped Today
Pfizer's acquisition of Array appeared to cause investors to wonder whether a big deal could be in store for Iovance.
These 3 Biotech Stocks Doubled in the First Half of 2019
Could the second half of the year be as much fun as the first?
